What is GBIM's gross margin?

GlobeImmune (GBIM) has a gross margin of 45% and a net margin of -91%.

What is GBIM's P/E ratio?

Track GlobeImmune (GBIM) P/E ratio, ROE, and valuation metrics over time.

Where can I see GBIM's full financials?

See GlobeImmune (GBIM) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

GlobeImmune (GBIM) Financials — Revenue, Earnings, Cash Flow

$0.00

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Sell · Power 45 · $575 mcap · 4M float · 0.012% daily turnover · Short 88% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$6M

Revenue

+55.1% YoY

$-2M

Net Income

+78.6% YoY

$-6M

Free Cash Flow

+12.2% YoY

45.4%

Gross Margin

-91.5%

Op. Margin

-91.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-66.2%

ROA-16.4%

ROIC25.0%

Valuation

P/E-0.0

P/B0.0

EV/EBITDA-1.7

Leverage

Debt/Equity0.00

Current Ratio2.28

Interest Cov.0.0x

Quality Scores

Piotroski F4/9

Altman Z-30.89

Beneish M-1.01